Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors

Psychoneuroendocrinology

Volumn 44, Issue , 2014, Pages 123-132

  Zamorano, Miriam ^a   Ledesma Colunga, Maria G ^a   Adán, Norma ^a   Vera Massieu, Camila ^a   Lemini, Maria ^a   Méndez, Isabel ^a   Moreno Carranza, Bibiana ^a   Neumann, Inga D ^b   Thebault, Stéphanie ^a   Martínez de la Escalera, Gonzalo ^a   Torner, Luz ^c   Clapp, Carmen ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

16K prolactin; Anxiety; Depression; Hypothalamus; Prolactin; Proteolytic cleavage; Stress; Vasoinhibins

Indexed keywords

BROMOCRIPTINE; MESSENGER RNA; PROLACTIN; RECOMBINANT HORMONE; RECOMBINANT VASOINHIBIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; VASH1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; ELECTROPHORESIS; ELEVATED PLUS MAZE TEST; FEMALE; FORCED SWIM TEST; GENE EXPRESSION; HORMONAL REGULATION; HORMONE ACTION; HORMONE METABOLISM; HYPOTHALAMUS; IMMOBILIZATION STRESS; MOLECULAR WEIGHT; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CELL CYCLE PROTEINS; DEPRESSION; FEMALE; HYPOTHALAMUS; PROLACTIN; RATS; RATS, WISTAR;

EID: 84899541064     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.03.006     Document Type: Article

References (55)

1. Aranda J., Rivera J.C., Jeziorski M.C., Riesgo-Escovar J., Nava G., Lopez-Barrera F., Quiroz-Mercado H., Berger P., Martinez de la Escalera G., Clapp C. Prolactins are natural inhibitors of angiogenesis in the retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:2947-2953.
2. Arnold E., Rivera J.C., Thebault S., Moreno-Paramo D., Quiroz-Mercado H., Quintanar-Stephano A., Binart N., Martinez de la Escalera G., Clapp C. High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes 2010, 59:3192-3197.
3. Barbanel G., Ixart G., Arancibia S., Assenmacher I. Probable extrapituitary source of the immunoreactive prolactin measured in the cerebrospinal fluid of unanesthetized rats by push-pull cannulation of the 3rd ventricle. Neuroendocrinology 1986, 43:476-482.
4. Ben-Jonathan N., Mershon J.L., Allen D.L., Steinmetz R.W. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr. Rev. 1996, 17:639-669.
5. Blume A., Bosch O.J., Miklos S., Torner L., Wales L., Waldherr M., Neumann I.D. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur. J. Neurosci. 2008, 27:1947-1956.
6. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 1998, 19:225-268.
7. Carola V., D'Olimpio F., Brunamonti E., Mangia F., Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav. Brain Res. 2002, 134:49-57.
8. Clapp C. Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms. Endocrinology 1987, 121:2055-2064.
9. Clapp C., Aranda J., Gonzalez C., Jeziorski M.C., Martinez de la Escalera G. Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol. Metab. 2006, 17:301-307.
10. Clapp C., Sears P.S., Nicoll C.S. Binding studies with intact rat prolactin and a 16K fragment of the hormone. Endocrinology 1989, 125:1054-1059.
11. Clapp C., Sears P.S., Russell D.H., Richards J., Levay-Young B.K., Nicoll C.S. Biological and immunological characterization of cleaved and 16K forms of rat prolactin. Endocrinology 1988, 122:2892-2898.
12. Clapp C., Thebault S., Jeziorski M.C., Martinez De La Escalera G. Peptide hormone regulation of angiogenesis. Physiol. Rev. 2009, 89:1177-1215.
13. Clapp C., Torner L., Gutierrez-Ospina G., Alcantara E., Lopez-Gomez F.J., Nagano M., Kelly P.A., Mejia S., Morales M.A., Martinez de la Escalera G. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10384-10388.
14. Clapp C., Weiner R.I. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 1992, 130:1380-1386.
15. Cook C.J. Oxytocin and prolactin suppress cortisol responses to acute stress in both lactating and non-lactating sheep. J. Dairy Res. 1997, 64:327-339.
16. Corbacho A.M., Macotela Y., Nava G., Eiserich J.P., Cross C.E., Martinez de la Escalera G., Clapp C. Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts. FEBS Lett. 2003, 544:171-175.
17. Corbacho A.M., Nava G., Eiserich J.P., Noris G., Macotela Y., Struman I., Martinez De La Escalera G., Freeman B.A., Clapp C. Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin. J. Biol. Chem. 2000, 275:13183-13186.
18. Debiec J. Peptides of love and fear: vasopressin and oxytocin modulate the integration of information in the amygdala. Bioessays 2005, 27:869-873.
19. DeVito W.J., Avakian C., Stone S. Proteolytic modification of prolactin by the female rat brain. Neuroendocrinology 1992, 56:597-603.
20. Dorshkind K., Horseman N.D. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 2000, 21:292-312.
21. Duenas Z., Torner L., Corbacho A.M., Ochoa A., Gutierrez-Ospina G., Lopez-Barrera F., Barrios F.A., Berger P., Martinez de la Escalera G., Clapp C. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest. Ophthalmol. Vis. Sci. 1999, 40:2498-2505.
22. Felicio L.F., Bridges R.S. Domperidone induces a probenecid-sensitive rise in immunoreactive prolactin in cerebroventricular perfusates in female rats. Brain Res. 1992, 573:133-138.
23. Galfione M., Luo W., Kim J., Hawke D., Kobayashi R., Clapp C., Yu-Lee L.Y., Lin S.H. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr. Purif. 2003, 28:252-258.
24. Giardino N.D., Friedman S.D., Dager S.R. Anxiety, respiration, and cerebral blood flow: implications for functional brain imaging. Compr. Psychiatry 2007, 48:103-112.
25. Gonzalez C., Corbacho A.M., Eiserich J.P., Garcia C., Lopez-Barrera F., Morales-Tlalpan V., Barajas-Espinosa A., Diaz-Munoz M., Rubio R., Lin S.H., Martinez de la Escalera G., Clapp C. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 2004, 145:5714-5722.
26. Grattan D.R., Kokay I.C. Prolactin: a pleiotropic neuroendocrine hormone. J. Neuroendocrinol. 2008, 20:752-763.
27. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
28. Lee K.W., Kim J.B., Seo J.S., Kim T.K., Im J.Y., Baek I.S., Kim K.S., Lee J.K., Han P.L. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J. Neurochem. 2009, 108:165-175.
29. Macotela Y., Aguilar M.B., Guzman-Morales J., Rivera J.C., Zermeno C., Lopez-Barrera F., Nava G., Lavalle C., Martinez de la Escalera G., Clapp C. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16kDa prolactin. J. Cell. Sci. 2006, 119:1790-1800.
30. Mangurian L.P., Walsh R.J., Posner B.I. Prolactin enhancement of its own uptake at the choroid plexus. Endocrinology 1992, 131:698-702.
31. Marti J., Armario A. Effects of diazepam and desipramine in the forced swimming test: influence of previous experience with the situation. Eur. J. Pharmacol. 1993, 236:295-299.
32. Mejia S., Morales M.A., Zetina M.E., Martinez de la Escalera G., Clapp C. Immunoreactive prolactin forms colocalize with vasopressin in neurons of the hypothalamic paraventricular and supraoptic nuclei. Neuroendocrinology 1997, 66:151-159.
33. Mejia S., Torner L.M., Jeziorski M.C., Gonzalez C., Morales M.A., de la Escalera G.M., Clapp C. Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system. Endocrine 2003, 20:155-162.
34. Moore K.E., Demarest K.T., Lookingland K.J. Stress, prolactin and hypothalamic dopaminergic neurons. Neuropharmacology 1987, 26:801-808.
35. Neumann I.D., Torner L., Wigger A. Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats. Neuroscience 2000, 95:567-575.
36. Park K.E., Pepine C.J. Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in review. Cleve. Clin. J. Med. 2010, 77(Suppl. 3):S40L 45.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, American Press, San Diego.
38. Rauch S.L., Shin L.M., Phelps E.A. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol. Psychiatry 2006, 60:376-382.
39. Reavley A., Fisher A.D., Owen D., Creed F.H., Davis J.R. Psychological distress in patients with hyperprolactinaemia. Clin. Endocrinol. (Oxf.) 1997, 47:343-348.
40. Reichlin S. Prolactin and growth hormone secretion in stress. Adv. Exp. Med. Biol. 1988, 245:353-376.
41. Roselli C.E., Bocklandt S., Stadelman H.L., Wadsworth T., Vilain E., Stormshak F. Prolactin expression in the sheep brain. Neuroendocrinology 2008, 87:206-215.
42. Schulkin J. Angst and the amygdala. Dialogues Clin. Neurosci. 2006, 8:407-416.
43. Shingo T., Gregg C., Enwere E., Fujikawa H., Hassam R., Geary C., Cross J.C., Weiss S. Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 2003, 299:117-120.
44. Siaud P., Manzoni O., Balmefrezol M., Barbanel G., Assenmacher I., Alonso G. The organization of prolactin-like-immunoreactive neurons in the rat central nervous system. Light- and electron-microscopic immunocytochemical studies. Cell Tissue Res. 1989, 255:107-115.
45. Sonigo C., Bouilly J., Carre N., Tolle V., Caraty A., Tello J., Simony-Conesa F.J., Millar R., Young J., Binart N. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J. Clin. Invest. 2012, 122:3791-3795.
46. Torner L., Maloumby R., Nava G., Aranda J., Clapp C., Neumann I.D. In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. Eur. J. Neurosci. 2004, 19:1601-1608.
47. Torner L., Mejia S., Lopez-Gomez F.J., Quintanar A., Martinez de la Escalera G., Clapp C. A 14-kilodalton prolactin-like fragment is secreted by the hypothalamo-neurohypophyseal system of the rat. Endocrinology 1995, 136:5454-5460.
48. Torner L., Neumann I.D. The brain prolactin system: involvement in stress response adaptations in lactation. Stress 2002, 5:249-257.
49. Torner L., Toschi N., Nava G., Clapp C., Neumann I.D. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses. Eur. J. Neurosci. 2002, 15:1381-1389.
50. Torner L., Toschi N., Pohlinger A., Landgraf R., Neumann I.D. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J. Neurosci. 2001, 21:3207-3214.
51. Vega C., Moreno-Carranza B., Zamorano M., Quintanar-Stephano A., Mendez I., Thebault S., Martinez de la Escalera G., Clapp C. Prolactin promotes oxytocin and vasopressin release by activating neuronal nitric oxide synthase in the supraoptic and paraventricular nuclei. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1701-R1708.
52. Viviani D., Stoop R. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog. Brain Res. 2008, 170:207-218.
53. Walker D.L., Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct. Funct. 2008, 213:29-42.
54. Walsh R.J., Slaby F.J., Posner B.I. A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. Endocrinology 1987, 120:1846-1850.
55. Yu-Lee L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 2002, 57:435-455.